Clinical Trial

Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management

Study acronym: SWT-PI
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2025 (before its estimated March 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy and safety of shock wave therapy (SWT) in reducing muscle spasticity in patients who have suffered a stroke. The main questions it aims to answer are: Does SWT reduce muscle tone and improve joint range of motion in post-stroke patients with spasticity? Does SWT improve the quality of life for these patients? What side effects, if any, occur during or after SWT? Researchers will compare SWT to conventional spasticity treatments to determine its effectiveness and potential advantages. Participants will: Undergo SWT sessions as part of their rehabilitation protocol over a period of 8 weeks. Attend follow-up visits to assess muscle tone, joint mobility, and overall functional improvement. Complete quality-of-life questionnaires to measure the therapy's impact on daily living.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-02-05; most recent amendment 2025-03-09.
Trial Details
NCT Number NCT06815328
Lead Sponsor University of Oviedo
Conditions Stroke, Spasticity, Post-stroke, Muscle Hypertonia, Neurological Disorders, Physiotherapy
Enrollment 50 participants
Start Date 2025-03-15
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-12